Side effects are likely to be low blood counts. This may not actually be a possibility because the first opening that they have is Oct. 22, and Dr. Nicholas doesn't want to wait that long to begin treatment. They have already decided the optimum dose to give, so if Paul got in this one, it would actually be like being in a phase 2 trial. They are both given by IV also. Dr. Nicholas didn't know how often.
Side effects are likely to be low blood counts.
Dr. Nicholas has to check first to see what dosage they are at in the trial. They know it takes a higher dose for brain tumors, and they may not be up to that dosage yet, so it's possible it may not make sense for Paul to be in this one. Dr. Nicholas had mentioned earlier that we might be able to petition to get Paul into the clinical trial of thalidomide for breast cancer at the U of C, but today he said they wouldn't accept brain tumor patients. Apparently he tried to get another one of his patients in and couldn't. He is, however, trying to get access to a clinical trial using thalidomide for brain tumors.